Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,389 public trials 159 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia

NCT00003829

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • CCOP - Illinois Oncology Research Association Peoria, Illinois, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
  • CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States
View all 17 locations
View Trial Details
Completed

Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients

NCT00254163

Conditions
B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +14 more
Locations
  • Cancer Centers of Florida, P.A. Ocoee, Florida, United States
  • Hope Center Terre Haute, Indiana, United States
  • Alliance Hematology Oncology PA Westminster, Maryland, United States
  • St Joseph Oncology, Inc Saint Joseph, Missouri, United States
View Trial Details
Completed

A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma

NCT01209130

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations
  • Stanford, California, United States
  • Denver, Colorado, United States
  • Washington D.C., District of Columbia, United States
  • Boston, Massachusetts, United States
View Trial Details
Completed

A Study of ABT-263 in Combination With Dose-Intensive Rituximab, or Dose-Intensive Rituximab Alone, in Previously Untreated Patients With B-Cell, Chronic Lymphocytic Leukemia (CLL)

NCT01087151

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Alhambra, California, United States
  • Antioch, California, United States
  • Berkeley, California, United States
  • Burbank, California, United States
View all 103 locations
View Trial Details

Related conditions